OPTIMA-AF Trial – One-month Dual Therapy After PCI Non-inferior to 12 Months, With Lower Bleeding in AF Patients
Key Points: • In patients with atrial fibrillation (AF) undergoing PCI, prolonged…
OCEAN: Ongoing Anticoagulation May Not be Necessary After 1-year Post Successful AF Ablation
Key Points: Atrial fibrillation (AF) increases the risk of stroke, and long-term…
CLOSURE-AF: Left Atrial Appendage Closure Fails to Achieve Noninferiority to Medical Therapy in AF Patients With High Bleeding Risk
Key Points: The CLOSURE AF study compared catheter-based left atrial appendage closure…
META-AF Trial – Metformin Reduces Arrhythmia Recurrence After AF Ablation in Overweight, Non-diabetic Patients
Key Points: Obesity is a well-established risk factor for atrial fibrillation (AF)…
DR10624, a First-in-Class FGF21/GLUCAGON/GLP-1 Receptor Triple Agonist, Significantly REDUCED Triglycerides, Lipids, and Liver Fat in Patients with Severe HYPERTRIGLYCERIDEMIA
Key Points: DR10624 is a first-in-class triple agonist of the FGF21, glucagon,…